Table 1.
Population characteristics according to the presence or absence of CAD
| Characteristics | Total | Non-CAD | CAD |
|---|---|---|---|
| (N = 272) | (N = 78) | (N = 194) | |
| Gender (men/women) | 178/94 | 39/39 | 139/55aa |
| Age (years) | 65.7 ± 10.2 | 62.4 ± 10.0 | 67.0 ± 10.1aa |
| BMI (kg/m2) | 24.8 ± 3.1 | 25.2 ± 3.2 | 24.6 ± 3.1 |
| W (cm) | 90.4 ± 9.2 | 90.1 ± 9.4 | 90.5 ± 9.1 |
| SBP (mmHg) | 130 (120-148) | 130 (120-143) | 130 (120-150) |
| DBP (mmHg) | 80 (70-85) | 80 (70-88) | 80 (70-83) |
| FPG (mmol/L) | 5.4 (5.0-6.3) | 5.5 (5.1-6.0) | 5.4 (5.0-6.5) |
| 2hPG (mmol/L) | 8.6 (6.7-11.8) | 8.1 (6.0-9.9) | 8.8 (6.7-12.5)a |
| HbA1c (%) | 6.2 (5.7-6.8) | 5.9 (5.6-6.4) | 6.2 (5.8-7.0)aa |
| GA (%) | 16.0 (14.0-19.0) | 15.0 (13.0-17.0) | 16.0 (15.0-19.0)aa |
| 1,5-AG (μg/mL) | 21.7 ± 10.1 | 23.9 ± 9.8 | 20.8 ± 10.1a |
| TC (mmol/L) | 4.4 ± 1.1 | 4.6 ± 1.0 | 4.3 ± 1.1a |
| TG (mmol/L) | 1.5 (1.1-2.2) | 1.6 (1.1-2.3) | 1.5 (1.1-2.1) |
| HDL-c (mmol/L) | 1.1 (0.9-1.3) | 1.1 (0.9-1.3) | 1.0 (0.9-1.3) |
| LDL-c (mmol/L) | 3.0 ± 0.9 | 3.1 ± 0.8 | 3.0 ± 1.0 |
| eGFR (mL/min/1.73 m2) | 89.0 ± 23.6 | 92.2 ± 24.9 | 87.8 ± 23.0 |
| CRP (mg/L) | 1.2 (0.6-3.1) | 1.4 (0.5-3.1) | 1.2 (0.6-2.9) |
| HOMA-IR | 4.0 (2.8-5.9) | 3.9 (2.8-5.9) | 4.0 (2.8-6.1) |
| CSI | 6 (2-12) | 0 (0-1) | 9 (4-14)aa |
| Smoking, n (%) | 121 (44.5) | 29 (37.2) | 92 (47.4) |
| Diabetes ratio, n (%) | 110 (40.4) | 24 (30.8) | 86 (44.3)a |
| Family history of CAD, n (%) | 116 (42.6) | 38 (48.7) | 78 (40.2) |
| Hypoglycemic therapy, n (%) | 62 (22.8) | 11 (14.1) | 51 (26.3)a |
| Anti-hypertensive therapy, n (%) | 185 (68.0) | 51 (65.4) | 134 (69.1) |
| Lipid-lowering therapy, n (%) | 76 (27.9) | 11 (14.1) | 65 (33.5)aa |
CAD: Coronary artery disease; BMI: Body mass index; W: Waist circumference; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FPG: Fasting plasma glucose; 2hPG: 2-hour postprandial glucose; HbA1c: Glycated hemoglobin A1c; GA: Glycated albumin; 1,5-AG: 1,5-anhydroglucitol; TC: Total cholesterol; TG: Triglyceride; HDL-c: High density lipoprotein cholesterol; LDL-c: Low density lipoprotein cholesterol; eGFR: Estimated glomerular filtration rate; CRP: C-reactive protein; HOMA-IR: Homeostasis model assessment-insulin resistance index; CSI: Coronary stenosis index.
For the subjects: a P < 0.05, CAD vs. non-CAD; aa P < 0.01, CAD vs. non-CAD. Data are presented as mean ± standard deviation or median (interquartile range).